2012 annual report lists five separate business segments with...

2012 annual report lists five separate business segments with all but one (contract manufacturing) declining in sales over the past year.

You are obviously right that contract manufacturing has been flagged as growing nicely but I note margins declined in 2012. Will this be the case again this year?

I guess I am a little less convinced about the other segments than you are - the text around celebrity slim and branded pharma is pretty vague and doesn't do enough to convince me that growth is necessarily locked-in for the December financials. But hey - that's what makes a market.

If I had to guess (and I stress guess) I would figure NPAT between $0-$1m for the 6 months to December. Suspect the market will be happy with $1m but disappointed if it's a doughnut. We shall see!